Cidara Therapeutics Inc (CDTX)
13.00
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
12.70
-0.30
(-2.31%)
After-Hours: 20:00
Cidara Therapeutics Profit Margin (Quarterly): -31.91% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -31.91% |
| September 30, 2023 | -64.26% |
| June 30, 2023 | -162.3% |
| March 31, 2023 | 12.35% |
| December 31, 2022 | -165.4% |
| September 30, 2022 | 36.76% |
| June 30, 2022 | -211.1% |
| March 31, 2022 | -257.2% |
| December 31, 2021 | -232.6% |
| Date | Value |
|---|---|
| September 30, 2021 | -255.6% |
| June 30, 2021 | 32.59% |
| March 31, 2021 | -759.6% |
| December 31, 2020 | -580.2% |
| September 30, 2020 | -729.8% |
| June 30, 2020 | -539.7% |
| March 31, 2020 | -574.7% |
| December 31, 2019 | -772.6% |
| September 30, 2019 | 15.91% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-772.6%
Minimum
Dec 2019
36.76%
Maximum
Sep 2022
-291.1%
Average
-221.8%
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 25.04% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -414.8% |
| Return on Assets | -34.99% |
| Return on Invested Capital | -414.8% |
| Gross Profit Margin (Quarterly) | 93.54% |
| Operating Margin (Quarterly) | -34.54% |
| Return on Net Operating Assets | -136.8% |